Hennion & Walsh Asset Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Hennion & Walsh Asset Management's ORGO Position: Q2 2026 in Review
Hennion & Walsh Asset Management reduced its Organogenesis Holdings (ORGO) stake by 0.87% in Q2 2026, selling an estimated $4.47K and leaving 208,997 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #742.
Hennion & Walsh Asset Management first reported a position in ORGO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.08M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Hennion & Walsh Asset Management held 208,997 shares of Organogenesis Holdings worth $508K as of Q2 2026.
- Hennion & Walsh Asset Management sold 1,829 Organogenesis Holdings shares in Q2 2026, an estimated $4.47K.
- Organogenesis Holdings made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #742 holding.
- Hennion & Walsh Asset Management first reported a position in Organogenesis Holdings in Q2 2025 and has held it in 5 quarters since.
- Hennion & Walsh Asset Management's Organogenesis Holdings position peaked at $1.08M in Q4 2025.
- 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.